S. C. Riemens
About
S. C. Riemens is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery.
According to data from OpenAlex, S. C. Riemens has authored 19 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in S. C. Riemens's work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Lipid metabolism and biosynthesis (4 papers). S. C. Riemens is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Lipid metabolism and biosynthesis (4 papers). S. C. Riemens collaborates with scholars based in Netherlands, Belgium and Japan. S. C. Riemens's co-authors include Arie van Tol, Robin P. F. Dullaart, Wim J. Sluiter, Robin P.F. Dullaart, Willem Sluiter, W.J. Sluiter, Klaas Hoogenberg, Jack J. M. Ligtenberg, B.G. Wolthers and Timon W. van Haeften and has published in prestigious journals such as Diabetes, Journal of Lipid Research and Diabetologia.
In The Last Decade
S. C. Riemens
19 papers receiving 563 citations
Peers
S. C. Riemens
Susan J. Murdoch United States
I.J.A.M. Jonkers Netherlands
S. E. Borggreve Netherlands
Song Lu China
Frank G. Perton Netherlands
Hyun Wha Chung South Korea
Amir F. Ayyobi Canada
E J Schaefer United States
C B Marenah United Kingdom
Hongzi Chen United States
Citations per year, relative to S. C. Riemens S. C. Riemens (= 1×)
peers
Susan J. Murdoch
Countries citing papers authored by S. C. Riemens
Since
Specialization
Citations
This map shows the geographic impact of S. C. Riemens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. C. Riemens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. C. Riemens more than expected).
Fields of papers citing papers by S. C. Riemens
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by S. C. Riemens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. C. Riemens. The network helps show where S. C. Riemens may publish in the future.
Co-authorship network of co-authors of S. C. Riemens
This figure shows the co-authorship network connecting the top 25 collaborators of S. C. Riemens. A scholar is included among the top collaborators of S. C. Riemens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. C. Riemens. S. C. Riemens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Dullaart, Robin P.F., S. C. Riemens, & Frans Boomsma. (2006). Plasma semicarbazide‐sensitive amine oxidase is moderately decreased by pronounced exogenous hyperinsulinemia but is not associated with insulin sensitivity and body fat. Scandinavian Journal of Clinical and Laboratory Investigation. 66(7). 559–566.
2.
Dullaart, Robin P.F., S. C. Riemens, Johan R. Meinardi, Bruce H. R. Wolffenbuttel, & Wim J. Sluiter. (2005). Plasma adiponectin is modestly decreased during 24‐hour insulin infusion but not after inhibition of lipolysis by Acipimox. Scandinavian Journal of Clinical and Laboratory Investigation. 65(6). 523–532.
3.
Minnee, Robert C., Pieter Stokkers, S. C. Riemens, & Daan W. Hommes. (2005). [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].. PubMed. 149(41). 2290–5.
4.
Riemens, S. C.. (2001). Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subject. Scandinavian Journal of Clinical and Laboratory Investigation. 61(1). 1–9.
5.
Riemens, S. C., et al.. (2000). Twenty-four hours of insulin infusion does not lower plasma lipoprotein(a) in healthy men. Scandinavian Journal of Clinical and Laboratory Investigation. 60(2). 119–123.
6.
Kerstens, M. N., et al.. (2000). Lack of relationship between 11β‐hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients*. Clinical Endocrinology. 52(4). 403–411.
7.
Riemens, S. C., Willem Sluiter, & Robin P.F. Dullaart. (2000). Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and Type II diabetes mellitus. Diabetologia. 43(4). 416–426.
8.
Riemens, S. C., Arie van Tol, W.J. Sluiter, & Robin P.F. Dullaart. (1999). Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.. Diabetes. 48(8). 1631–1637.
9.
Tol, Arie van, Matti Jauhiainen, Teus van Gent, et al.. (1999). Plasma phospholipid transfer protein activity, high density lipoprotein subfractions and atherogenesis: Studies in mice and man. Atherosclerosis. 144. 84–84.
10.
Riemens, S. C., Arie van Tol, W.J. Sluiter, & Robin P. F. Dullaart. (1999). Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities. Journal of Lipid Research. 40(8). 1459–1466.
11.
Riemens, S. C., et al.. (1999). Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. Journal of Lipid Research. 40(8). 1467–1474.
12.
Riemens, S. C., Arie van Tol, Willem Sluiter, & Robin P. F. Dullaart. (1998). Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. Diabetologia. 41(8). 929–934.
13.
Riemens, S. C., Arie van Tol, Wim J. Sluiter, & Robin P. F. Dullaart. (1998). Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis. 140(1). 71–79.
14.
Dullaart, Robin P.F., et al.. (1998). High-density lipoprotein cholesterol is related to the TaqIB cholesteryl ester transfer protein gene polymorphism and smoking, but not to moderate alcohol consumption in insulin-dependent diabetic men. Scandinavian Journal of Clinical and Laboratory Investigation. 58(3). 251–258.
15.
Riemens, S. C., Arie van Tol, Klaas Hoogenberg, et al.. (1997). Higher high density lipoprotein cholesterol associated with moderate alcohol consumption is not related to altered plasma lecithin: cholesterol acyltransferase and lipid transfer protein activity levels. Clinica Chimica Acta. 258(1). 105–115.
16.
Riemens, S. C., Jack J. M. Ligtenberg, & Robin P. F. Dullaart. (1997). Hyperglycemia-induced hyperinsulinemia acutely lowers plasma apolipoprotein B but not lipoprotein (a) in man. Clinica Chimica Acta. 261(2). 149–158.
17.
Tol, Arie van, et al.. (1997). Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scandinavian Journal of Clinical and Laboratory Investigation. 57(2). 147–157.
18.
Dullaart, Robin P.F., Klaas Hoogenberg, S. C. Riemens, et al.. (1997). Cholesteryl Ester Transfer Protein Gene Polymorphism Is a Determinant of HDL Cholesterol and of the Lipoprotein Response to a Lipid-Lowering Diet in Type 1 Diabetes. Diabetes. 46(12). 2082–2087.
19.
Riemens, S. C., Ad H. Oostdijk, J. J. van Doormaal, et al.. (1996). Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. Osteoporosis International. 6(3). 213–218.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Susan J. Murdoch Breakdown of academic impact, for papers by I.J.A.M. Jonkers Breakdown of academic impact, for papers by S. E. Borggreve Breakdown of academic impact, for papers by Song Lu Breakdown of academic impact, for papers by Frank G. Perton Breakdown of academic impact, for papers by Hyun Wha Chung Breakdown of academic impact, for papers by Amir F. Ayyobi Breakdown of academic impact, for papers by E J Schaefer Breakdown of academic impact, for papers by C B Marenah Breakdown of academic impact, for papers by Hongzi Chen